EBV阳性淋巴结T/NK细胞淋巴瘤以噬血细胞综合征起病一例并文献复习
本文回顾性总结1例以噬血细胞综合征(HLH)为首发表现的EBV阳性淋巴结T/NK细胞淋巴瘤患者的临床资料,并结合文献复习。患者男性58岁,因发热6天就诊,虽经积极规范治疗,确诊后不足2个月死亡。该病临床罕见、易误诊,多数确诊时已属晚期,目前尚无标准治疗方案,预后极差。
要点
- EBV阳性淋巴结T/NK细胞淋巴瘤临床罕见,易误诊。
- 以HLH为首发表现时需早期识别并排查本病。
- 多数患者确诊时已属晚期,尚无标准治疗,预后极差。
核心结论
- EBV阳性淋巴结T/NK细胞淋巴瘤临床罕见且易误诊,多数确诊时已属晚期,目前尚无标准治疗方案,预后极差。
研究设计与样本
- 回顾性总结1例以HLH起病的EBV阳性淋巴结T/NK细胞淋巴瘤患者的临床资料并结合相关文献复习。
主要发现
- 患者为58岁男性,因发热6天就诊,首发临床表现为HLH。
- 虽经积极规范治疗,患者最终于确诊后不足2个月死亡。
临床怎么用
- 对以HLH为首发表现的患者应提升对EBV阳性淋巴结T/NK细胞淋巴瘤的早期识别与诊断能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To enhance our understanding of Epstein-Barr virus (EBV) -positive nodal T/natural killer (NK) cell lymphoma and improve the early recognition and diagnosis of patients presenting with hemophagocytic syndrome (HLH) as the initial manifestation, this article retrospectively summarizes clinical data for a case of EBV-positive nodal T/NK cell lymphoma presenting with HLH at onset and reviews relevant literature. The patient, a 58-year-old male, presented with a "fever for 6 days" as the chief complaint, with the initial clinical manifestation being HLH. Despite active standard treatment, the patient died less than 2 months after diagnosis. EBV-positive nodal T/NK cell lymphoma is clinically rare and easily misdiagnosed. Most patients are diagnosed at an advanced stage. Furthermore, there is currently no standard treatment, leading to an extremely poor prognosis. 为增进对EB病毒(EBV)阳性淋巴结T/NK细胞淋巴瘤的认识,提升以噬血细胞综合征(HLH)为首发表现患者的早期识别与诊断能力,本文回顾性总结1例以HLH起病的EBV阳性淋巴结T/NK细胞淋巴瘤患者的临床资料,并结合相关文献进行复习。患者男性,58岁,因"发热6 d"就诊,首发临床表现为HLH,虽经积极规范治疗,最终仍于确诊后不足2个月死亡。EBV阳性淋巴结T/NK细胞淋巴瘤临床罕见,易误诊,多数患者确诊时已属晚期,目前尚无标准治疗方案,预后极差。.
引用
- Qiu JY, Liu YP, Mi HL, et al. [Epstein-Barr virus-positive nodal T/NK-cell lymphoma presenting with hemophagocytic lymphohistiocytosis: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 42161663. doi:10.3760/cma.j.cn121090-20250922-00431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。